Intravaginal ring providing dual protection is first of its kind to enter a clinical trial
Women’s reproductive health may never be the same, thanks to Northwestern University biomedical engineer Patrick Kiser and his first-of-its-kind intravaginal ring that reliably delivers an antiretroviral drug and a contraceptive for months.
Kiser’s one ring delivers two drugs that do three important things: the device is designed to protect against HIV and herpes as well as unwanted pregnancy. It will be the first device with the potential to offer this protection to be tested in women.
The easy-to-use ring delivers controlled doses of tenofovir (a common antiretroviral drug) and levonorgestrel (a contraceptive) for 90 days. The rings are being manufactured now, and the device soon will undergo its first test in women.
Details of the development of the ring, a device that represents a lot of ‘firsts,’ was published March 5 by PLOS ONE, a peer-reviewed, open-access online journal.
According to the World Health Organization, 35 million people around the world live with HIV, and 222 million women would like to delay or stop childbearing but are not using any method of contraception.
“I suspect women will use the ring primarily for contraception, but they also will benefit from protection against sexually transmitted diseases,” said Kiser, an expert in intravaginal drug delivery. “And for women in the developing world in particular, unwanted pregnancy can have significant health, economic and cultural consequences. We want to motivate women to use this ring.”
The ring, 5.5 centimeters in diameter, is simple yet complex. Kiser and his colleagues worked painstakingly for five years, engineering the three materials that make up the ring and optimizing the device to reliably deliver fixed and efficacious doses of two medicines over a long period of time.
“A lot of engineering has gone into developing the ring,” said Kiser, senior author of the paper. “It represents two Ph.D. theses — one Ph.D. for the larger section containing the antiretroviral drug and another Ph.D. for the smaller section containing the contraceptive.”
Kiser is a faculty member in the department of biomedical engineering at the McCormick School of Engineering and Applied Science and in the department of obstetrics and gynecology at Northwestern University Feinberg School of Medicine.
The ring is easily inserted in the vagina and stays in place for three months. And because the tenofovir is delivered at the site of transmission, the ring — known as the tenofovir levonorgestrel IVR — utilizes a smaller dose than pills. The levonorgestrel released by the ring is the same drug as that used in certain contraceptive pills and in an intrauterine device.
“This system represents a significant advance in vaginal drug delivery technology and is the first in a new class of long-acting multipurpose prevention drug delivery systems,” say the authors in the study. They also report details of the ring’s engineering, safety, stability and drug release.
“The differences between the two drugs are huge, which presented us with a design challenge,” Kiser said. “Tenofovir is highly water soluble while levonorgestrel is highly water insoluble. And the daily dose is different: the ring delivers about 10 milligrams of tenofovir and only 10 micrograms of levonorgestrel. Our scientific hurdle was finding a way to manufacture a dual-purpose ring that got the device into the clinic.”
Tenofovir is taken orally by 3.5 million HIV-infected people worldwide, and it also has been studied as a gel. The drug inhibits HIV and HSV-2 (herpes simplex virus-2) replication in susceptible cells.
Previous studies have demonstrated that antiretroviral drugs can prevent HIV infection, but existing methods for delivering the drug fall short. Pills must be taken daily and require high doses; some women may prefer a longer-lasting method, such as the ring, versus methods used at the time of sex, such as a gel.
Kiser’s combination ring promises much more. The strength of the device stems from its unique polymer construction: its elastomer swells in the presence of fluid (such as that found in the human body), delivering up to 100 times more of the tenofovir than current intravaginal ring technology, which have release rates that decline over time.
“Products only work when they are used,” said co-author David Friend, product development director at CONRAD, which develops reproductive health technologies for low-income countries and is affiliated with Eastern Virginia Medical School.
“By having a ring that can remain in the body for up to 90 days, our hope is that this ring will offer a solution to increase adherence, and therefore provide greater protection against HIV while also preventing pregnancy,” he said.
The Latest on: Birth control
via Google News
The Latest on: Birth control
- The View erupts after Meghan McCain rants about birth control and eugenicson September 6, 2019 at 9:44 am
Whoopi Goldberg repeatedly fact-checked Meghan McCain’s analysis on “The View” of Sen. Bernie Sanders’ remarks about population control in light of climate change. The Democratic presidential ...
- This Is What Can Happen To Your Body And Mind When You Quit Birth Controlon September 5, 2019 at 4:21 pm
The pill is like the Swiss Army knife of birth control: It does so much more than you'd think. Oral contraceptives prevent unplanned pregnancy, regulate your cycle, tone down menstrual cramps, and can ...
- Why Reversible Vasectomies Will Never Be a Viable Male Birth Control Optionon September 5, 2019 at 2:42 pm
Emily Dunkler is sick of the birth control implant she's had in her arm for the past three years. She believes it's caused her to gain 70 pounds and made her existing anxiety and depression worse.
- Bernie Sanders said birth control can help fight climate change. Here's why it's such a thorny issue.on September 5, 2019 at 10:23 am
Bernie Sanders caused a stir at the CNN climate change town hall after saying reproductive rights and birth control could help fight climate change.
- Planned Parenthood offers Iowans birth control through mobile appon September 4, 2019 at 8:12 pm
GOOD EVENING, THANK YOU FOR JOINING US. WOMEN ACROSS IOWA CAN NOW ACCESS BIRTH CONTROL, WITHOUT SEEING A DOCTOR. >> IT INVOLVES YOUR PHONE AND AN APP. >> HERE’S KCCI’S MAX DIEKNEITE. >> STEVE & STACEY ...
- Planned Parenthood app to let users order birth control in every stateon September 4, 2019 at 5:09 pm
The Trump administration is doing everything it can to undermine Planned Parenthood's law-abiding, science-based reproductive health services. But Planned Parenthood has a powerful weapon in its ...
- Planned Parenthood birth control app to be available nationwide by 2020on September 4, 2019 at 4:06 pm
Planned Parenthood says its app will be available in all 50 states by 2020. Planned Parenthood, a reproductive health care non profit, said Wednesday that its Planned Parenthood Direct app would ...
- Planned Parenthood birth control app to expand to all 50 states by end of 2020on September 4, 2019 at 1:24 pm
Planned Parenthood says it will expand its telemedicine app to all 50 states by the end of 2020, making it easier for women to access birth control and other prescription drugs without visiting a ...
- Need birth control? Planned Parenthood says there's an app for thaton September 4, 2019 at 11:52 am
Weeks after a high-profile exit from Title X, Planned Parenthood has launched a mobile app designed at providing birth control and urinary tract infection (UTI) treatment to women struggling to find ...
- Planned Parenthood is expanding its birth control app to all 50 states in the wake of Trump's massive funding cuton September 4, 2019 at 11:04 am
Planned Parenthood is seeking a new approach to expand health services after the recent $60 million in funding cuts from Trump's "gag rule." ...
via Bing News